Settled

Do GIP/GLP-1 & amylin agonists improve lipids versus placebo?

Mostly studied in obesity & overweight.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Very likely. So far, established.

NoUnsureYes
Belief
0.86 (range 0.61–0.96)
Trials for
6
Trials against
1
Inconclusive
1

Already under way

The evidence so far

Registered trials
78
With posted results
10
Published papers
1

Of 61 decided analyses: 36 favor gip/glp-1 & amylin agonists, 13 find no difference, 12 favor the comparator.

Papers

Trials

See every trial in the evidence map →